BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of $18.94 billion. The enterprise value is $17.28 billion.
Important Dates
The next estimated earnings date is Monday, February 24, 2025, before market open.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BeiGene has 106.47 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 106.47M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 4.50% |
| Owned by Institutions (%) | 44.85% |
| Float | 64.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.54 |
| Forward PS | 2.53 |
| PB Ratio | 5.50 |
| P/TBV Ratio | 5.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.94 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -57.74 |
Financial Efficiency
Return on equity (ROE) is -23.22% and return on invested capital (ROIC) is -12.29%.
| Return on Equity (ROE) | -23.22% |
| Return on Assets (ROA) | -9.58% |
| Return on Capital (ROIC) | -12.29% |
| Revenue Per Employee | $316,161 |
| Profits Per Employee | -$80,606 |
| Employee Count | 10,600 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.44 |
Taxes
In the past 12 months, BeiGene has paid $53.11 million in taxes.
| Income Tax | 53.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.56% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +7.56% |
| 50-Day Moving Average | 192.89 |
| 200-Day Moving Average | 179.09 |
| Relative Strength Index (RSI) | 40.75 |
| Average Volume (20 Days) | 363,820 |
Short Selling Information
The latest short interest is 1.38 million, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 1.38M |
| Short Previous Month | 1.33M |
| Short % of Shares Out | 1.29% |
| Short % of Float | 2.15% |
| Short Ratio (days to cover) | 3.06 |
Income Statement
In the last 12 months, BeiGene had revenue of $3.35 billion and -$854.42 million in losses. Loss per share was -$8.19.
| Revenue | 3.35B |
| Gross Profit | 2.80B |
| Operating Income | -886.48M |
| Pretax Income | n/a |
| Net Income | -854.42M |
| EBITDA | -794.98M |
| EBIT | -886.48M |
| Loss Per Share | -$8.19 |
Full Income StatementBalance Sheet
The company has $2.71 billion in cash and $1.05 billion in debt, giving a net cash position of $1.66 billion or $15.61 per share.
| Cash & Cash Equivalents | 2.71B |
| Total Debt | 1.05B |
| Net Cash | 1.66B |
| Net Cash Per Share | $15.61 |
| Equity (Book Value) | 3.45B |
| Book Value Per Share | 32.32 |
| Working Capital | 1.89B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$649.87 million and capital expenditures -$541.71 million, giving a free cash flow of -$1.14 billion.
| Operating Cash Flow | -649.87M |
| Capital Expenditures | -541.71M |
| Free Cash Flow | -1.14B |
| FCF Per Share | -$10.71 |
Full Cash Flow StatementMargins
Gross margin is 83.67%, with operating and profit margins of -26.45% and -25.50%.
| Gross Margin | 83.67% |
| Operating Margin | -26.45% |
| Pretax Margin | -23.91% |
| Profit Margin | -25.50% |
| EBITDA Margin | -23.72% |
| EBIT Margin | -26.45% |
| FCF Margin | n/a |